Hetland ML, Haavardsholm EA, Rudin A, NORD-STAR study group et al (2020) Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial. BMJ 371:m4328. https://doi.org/10.1136/bmj.m4328

Article  PubMed  PubMed Central  Google Scholar 

van Ouwerkerk L, Verschueren P, Boers M et al (2024) Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? Ann Rheum Dis 83(1):65–71. https://doi.org/10.1136/ard-2023-224270

Article  PubMed  Google Scholar 

Cutolo M, Shoenfeld Y, Bogdanos DP et al (2023) To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate. Autoimmun Rev 23(1):103437. https://doi.org/10.1016/j.autrev.2023.103437

Article  CAS  PubMed  Google Scholar 

Bergstra SA, Sepriano A, Kerschbaumer A et al (2023) Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 82(1):81–94. https://doi.org/10.1136/ard-2022-223358

Article  CAS  PubMed  Google Scholar 

George MD, Baker JF, Winthrop K et al (2020) Risk for serious infection with low-dose glucocorticoids in patients with rheumatoid arthritis: a Cohort Study. Ann Intern Med 173(11):870–878. https://doi.org/10.7326/M20-1594

Article  PubMed  PubMed Central  Google Scholar 

So H, Lam TO, Meng H, Lam SHM, Tam LS (2023) Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study. Ann Rheum Dis 82(11):1387–1393. https://doi.org/10.1136/ard-2023-224185

Article  CAS  PubMed  Google Scholar 

Smolen JS, Landewé RBM, Bergstra SA et al (2023) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis Ann Rheum Dis 82(1):3–18. https://doi.org/10.1136/ard-2022-223356

Article  CAS  PubMed  Google Scholar 

Fraenkel L, Bathon JM, England BR et al (2021) 2021 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 73(7):1108–1123. https://doi.org/10.1002/art.41752

Article  PubMed  Google Scholar 

Lau CS, Chia F, Dans L et al (2019) 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis. Int J Rheum Dis 22(3):357–375. https://doi.org/10.1111/1756-185X.13513

Article  PubMed  Google Scholar 

Chinese Rheumatology Association (2018) Zhonghua nei ke za zhi 57(4):242–251. https://doi.org/10.3760/cma.j.issn.0578-1426.2018.04.004. [2018 Chinese guideline for the diagnosis and treatment of rheumatoid arthritis]Chinese

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative (2014) The strengthening the reporting of Observational studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 12(12):1495–1499. https://doi.org/10.1016/j.ijsu.2014.07.013

Article  Google Scholar 

Zimba O, Gasparyan AY (2023) Designing, conducting, and reporting Survey studies: a primer for researchers. J Korean Med Sci 38(48):e403. https://doi.org/10.3346/jkms.2023.38.e403

Article  PubMed  PubMed Central  Google Scholar 

Fan Y, Geng Y, Wang Y et al (2022) Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines. Ann Rheum Dis 81(3):443–445. https://doi.org/10.1136/annrheumdis-2021-221736

Article  CAS  PubMed  Google Scholar 

Geng Y, Fan Y, Wang Y et al (2023) Flare and change in disease activity among patients with stable rheumatoid arthritis following coronavirus disease 2019 vaccination: a prospective Chinese cohort study. Chin Med J (Engl) 136(19):2324–2329. https://doi.org/10.1097/CM9.0000000000002562

Article  PubMed  Google Scholar 

Suh HW, Ko Y, Moon S et al (2022) A multicenter registry of neuropsychiatric outpatients in Korean medicine hospitals (KMental): protocol of a prospective, multicenter, registry study. Med (Baltim) 101(49):e32151. https://doi.org/10.1097/MD.0000000000032151

Article  Google Scholar 

Röhrig B, du Prel JB, Wachtlin D, Kwiecien R, Blettner M (2010) Sample size calculation in clinical trials: part 13 of a series on evaluation of scientific publications. Dtsch Arztebl Int 107(31–32):552–556. https://doi.org/10.3238/arztebl.2010.0552

Article  PubMed  PubMed Central  Google Scholar 

Xie W, Yang X, Zhang Z (2019) The plight and light of treating rheumatoid arthritis in China. Lancet Rheumatol 1(2):e81–e82. https://doi.org/10.1016/S2665-9913(19)30039-6

Article  PubMed  Google Scholar 

Li Y, Zhang X, Xiang Z et al (2023) Public attitudes about the Use of Gene Therapy in Mainland China. JAMA Netw Open 6(8):e2328352. https://doi.org/10.1001/jamanetworkopen.2023.28352

Article  PubMed  PubMed Central  Google Scholar 

Ocon AJ, Reed G, Pappas DA, Curtis JR, Kremer JM (2021) Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis. Ann Rheum Dis 80(12):1522–1529. https://doi.org/10.1136/annrheumdis-2021-220577

Article  PubMed  Google Scholar 

Enríquez-Luna A, Soto-Fajardo C, Carranza-Enríquez F, Clavijo-Cornejo D, Lopez-Reyes A, Pineda C (2024) Miliarial-type gout in association with chronic use of glucocorticoids. Rheumatol Int 44(3):543–547. https://doi.org/10.1007/s00296-023-05486-0

Article  PubMed  Google Scholar 

Xie W, Yang X, Ji L, Zhang Z (2020) Incident diabetes associated with hydroxychloroquine, methotrexate, biologics and glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 50(4):598–607. https://doi.org/10.1016/j.semarthrit.2020.04.005

Article  CAS  PubMed  Google Scholar 

Coburn BW, Baker JF, Hsu JY et al (2024) Association of Cardiovascular Outcomes with Low-Dose Glucocorticoid Use in Patients with Rheumatoid Arthritis. Arthritis Rheumatol. 2024 Jun 24. Epub ahead of print. https://doi.org/10.1002/art.42928

Schenfeld J, Iles J, Trivedi M, Accortt NA (2017) Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis. Rheumatol Int 37(7):1075–1082. https://doi.org/10.1007/s00296-017-3679-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yagiz B, Coskun BN, Pehlivan Y et al (2021) In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids? Rheumatol Int 41(11):1915–1924. https://doi.org/10.1007/s00296-021-04939-8

Article  CAS  PubMed  Google Scholar 

Szekanecz Z, Buch MH, Charles-Schoeman C et al (2024) Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nat Rev Rheumatol. 2024 20(2):101–115. https://doi.org/10.1038/s41584-023-01062-9

Tanaka Y (2023) Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needs. Rheumatology (Oxford) 60(6):vi12–vi20. https://doi.org/10.1093/rheumatology/keab609

Article  Google Scholar 

Metselaar JM, Middelink LM, Wortel CH et al (2022) Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: a randomized controlled clinical trial. J Control Release 341:548–554. https://doi.org/10.1016/j.jconrel.2021.12.007

Article  CAS  PubMed  Google Scholar 

Berger M, Rehwinkel H, Schmees N et al (2017) Discovery of new selective glucocorticoid receptor agonist leads. Bioorg Med Chem Lett 27(3):437–442. https://doi.org/10.1016/j.bmcl.2016.12.047

Article  CAS  PubMed  Google Scholar 

Hu X, Du S, Tunca C et al (2011) The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation. Endocrinology 152(8):3123–3134. https://doi.org/10.1210/en.2010-1447

Article  CAS  PubMed  Google Scholar 

Pofi R, Caratti G, Ray DW, Tomlinson JW (2023) Treating the Side effects of Exogenous glucocorticoids; can we separate the good from the bad? Endocr Rev 44(6):975–1011. https://doi.org/10.1210/endrev/bnad016

Article  PubMed  PubMed Central  Google Scholar 

Xie W, Huang H, Li G et al (2021) Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020. Ann Rheum Dis 80(8):997–1003.